Business Description
Sihuan Pharmaceutical Holdings Group Ltd
NAICS : 325414
ISIN : BMG8162K1137
Compare
Compare
Traded in other countries / regions
00460.Hong KongSHPHF.USATEL1.Germany IPO Date
2010-10-28Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.7 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 5.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.6 | |||||
| Beneish M-Score | -3.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.3 | |||||
| 3-Year EBITDA Growth Rate | 8.7 | |||||
| 3-Year EPS without NRI Growth Rate | 37.5 | |||||
| 3-Year Book Growth Rate | -20.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.52 | |||||
| 9-Day RSI | 52.39 | |||||
| 14-Day RSI | 48.24 | |||||
| 6-1 Month Momentum % | -5 | |||||
| 12-1 Month Momentum % | -29.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 1.06 | |||||
| Days Inventory | 385.97 | |||||
| Days Sales Outstanding | 79.83 | |||||
| Days Payable | 130.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 7.12 | |||||
| 3-Year Dividend Growth Rate | -5.6 | |||||
| Forward Dividend Yield % | 7.31 | |||||
| 5-Year Yield-on-Cost % | 2.39 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 7.11 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.64 | |||||
| Operating Margin % | -10.29 | |||||
| Net Margin % | -2.9 | |||||
| FCF Margin % | -38.31 | |||||
| ROE % | -1.19 | |||||
| ROA % | -0.45 | |||||
| ROIC % | -4.37 | |||||
| ROC (Joel Greenblatt) % | 3.68 | |||||
| ROCE % | 1.21 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 6 | |||||
| PS Ratio | 2.44 | |||||
| PB Ratio | 1.04 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| EV-to-EBIT | 13.47 | |||||
| EV-to-EBITDA | 6.32 | |||||
| EV-to-Revenue | 0.78 | |||||
| EV-to-FCF | -1.68 | |||||
| Price-to-Projected-FCF | 0.46 | |||||
| Price-to-Median-PS-Value | 0.35 | |||||
| Earnings Yield (Greenblatt) % | 7.42 | |||||
| FCF Yield % | -15.47 | |||||
| Forward Rate of Return (Yacktman) % | 28.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sihuan Pharmaceutical Holdings Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 2,035.02 | ||
| EPS (TTM) (HK$) | -0.007 | ||
| Beta | 1.19 | ||
| Volatility % | 30.55 | ||
| 14-Day RSI | 48.24 | ||
| 14-Day ATR (HK$) | 0.021241 | ||
| 20-Day SMA (HK$) | 0.5295 | ||
| 12-1 Month Momentum % | -29.63 | ||
| 52-Week Range (HK$) | 0.49 - 0.83 | ||
| Shares Outstanding (Mil) | 9,330 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sihuan Pharmaceutical Holdings Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Frequently Asked Questions
What is Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)'s stock price today?
The current price of HKSE:00460 is HK$0.54. The 52 week high of HKSE:00460 is HK$0.83 and 52 week low is HK$0.49.
When is next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)?
The next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 2024-08-29 Est..
Does Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) pay dividends? If so, how much?
The Dividend Yield %  of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 7.12% (As of Today), Highest Dividend Payout Ratio of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) was 0.4. The lowest was 0.11. And the median was 0.31. The  Forward Dividend Yield % of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 7.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers